Outlook Therapeutics, Inc.
OTLK · Iselin, NJ
Works in Cardiovascular · Ophthalmology
Outlook Therapeutics, Inc. is a clinical trial sponsor based in Iselin, NJ, listed as OTLK. It has 1 active clinical trial with 120 planned participants, in Cardiovascular and Ophthalmology. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Financials · OTLK
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Outlook Therapeutics, Inc
Outlook Therapeutics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 120 planned participants, in Cardiovascular, Ophthalmology. Since 2021 it has completed 4 trials and stopped 0 early.
Outlook Therapeutics, Inc is based in Iselin, NJ and is listed as OTLK. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Outlook Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-03.
Approve Suite is not affiliated with Outlook Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.